Increase of serum complement levels in cancer patients with progressing tumors
Authors:
- Walter De CockWCWalter De Cock
Open Access
Abstract
Complement levels (CH50, C3, C4 and C1q) were determined in sera of 90 healthy subjects and 200 cancer patients. Complement levels of cancer patients were significantly higher than those of the healthy subjects, but there was a stage-linked increase of complement levels. Patients in remission had nearly normal complement levels, but patients with local tumor had increased complement levels, and a further increase was observed in patients with distant metastases. Treatment of these patients with radiotherapy or cytostatic drugs lowered the complement levels. At the terminal phase of the disease we also noted a drop in complement levels.Keywords
This publication has 5 references indexed in Scilit:
- Die Bestimmung von β1C/A (Komplementfaktor 3) bei malignen Lymphomen, Myelom und Morbus WaldenströmDMW - Deutsche Medizinische Wochenschrift, 1972
- Cellular Immunity Against Tumor Antigens1969
- Immunochemical quantitation of antigens by single radial immunodiffusionImmunochemistry, 1965
- Behavior of Total Serum Complement in Hodgkin’s Disease and Other Malignant LymphomasBlood, 1959
- Effect of Nitrogen Mustard on Serum Complement in vitro and in Patients with Neoplastic DiseaseExperimental Biology and Medicine, 1951